RxDoctor Payments Data

Lydia Ferrell, MD

Pain Medicine · Indianapolis, INNPI 1760476071

Payments from drug & device makers

$1,692in general payments, 2019–2025

Across 91 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GRT US Holding, Inc.$211
  • Collegium Pharmaceutical, Inc.$209
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$204
  • Pfizer$167
  • AbbVie$119
  • Lilly USA, LLC$118
  • plus $665 from 20 others

What the payments were for

  • Food & beverage$1,692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,692 in reported general payments places this provider in the 35th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$88,921
Medicare patients
113
Services billed
1,266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,366$27,715
ZubsolvBuprenorphine Hcl/Naloxone Hcl30$20,111
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen620$16,174
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl176$13,616
SuboxoneBuprenorphine Hcl/Naloxone Hcl26$11,969
Gabapentin419$8,494
Emgality PenGalcanezumab-Gnlm11$7,271
Pregabalin219$5,360
Buprenorphine19$5,275
Diclofenac Sodium241$3,967
Cyclobenzaprine Hcl320$2,148
Oxycodone Hcl123$1,887
Tramadol Hcl184$1,867
Methadone Hcl94$1,630
Tizanidine Hcl169$1,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Orexo US, Inc.Zubsolv$60$20,11130 claims
Indivior Inc.Suboxone$32$11,96926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 128 pain medicine providers in Indiana.

Other pain medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →